Ratings by Jefferies (Matthew Andrews)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/25/2018 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2018 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 9/13/2018 | Cara Therapeutics | CARA | New Coverage | Buy (N/A) |
20.74 (15.37) |
-25.89% | Details | |
| 8/20/2018 | Liquidia Technologies | LQDA | New Coverage | Buy (N/A) |
14.00 (18.70) |
33.57% | Details | |
| 8/13/2018 | Gemphire Therapeutics | GEMP | Downgrade | Hold (Buy) |
3.27 (0.30) |
-90.83% | Details |
